
Credit: Unsplash/CC0 Public Domain
The new study by the University of Exeter, published in Cell Host Microbe, has cast new light on how to best combine antibiotics and phage therapy
New research has moved a step closer to harnessing viruses to fight bacterial infection, reducing the threat of antibiotic resistance.
A growing number of infections, including pneumonia, tuberculosis, gonorrhoea, and salmonellosis, are developing antibiotic resistance, which means they becoming harder to treat, resulting in higher death rates, longer hospital stays and higher costs.
Phage therapy is the concept of using viruses (known as phage) that are harmless to humans to kill bacteria. Phage therapy can be used in combination with antibiotics to cure infections more effectively, and reduce the opportunity for bacteria to develop antibiotic resistance. However, bacteria can also evolve resistance to phages.
The new study by the University of Exeter, published in Cell Host Microbe, has cast new light on how to best combine antibiotics and phage therapy. Researchers conducted laboratory experiments on Pseudomonas aeruginosa a bacterium which causes disease in immunocompromised and cystic fibrosis patients. They exposed the bacterium to eight types of antibiotics – and found differences in the mechanisms by which the bacteria evolve resistance to phages, which affect how harmful they are.
Viruses penetrate molecules on the cell surface to infect bacteria. Like the human immune system, bacteria have their own CRISPR defence system, made up of proteins that fight off infection. As in human immune responses, this means that the virus infects the bacteria, and is then killed. In the process, the bacteria’s CRISPR system learns to recognise and attack the virus in future.
However, the bacteria have a second defence option. They can also change their own cell surface to ward off infection, losing the receptor to which phages normally attach. This option comes with a cost to bacteria – the bacteria become less virulent, meaning they no longer cause disease, or the disease becomes less severe.
In the study, four of the eight antibiotics tested caused a dramatic increase in the levels of CRISPR-based immunity. These antibiotics are all bacteriostatic – they do not directly kill cells but act by slowing down cell growth.
Professor Edze Westra, of the University of Exeter, said; “Antibiotic resistance is a major public health issue, and we need to take swift and urgent action. Phage therapy could be an important part of the toolkit, in reducing antibiotic use, and in using them in combination to increase their efficiency. We found that by changing the type of antibiotics that are used in combination with phage, we can manipulate how bacteria evolve phage resistance, increasing the chances that treatment is effective. These effects should be considered during phage-antibiotic combination therapy, given their important consequences for pathogen virulence.”
Phage therapy was first used in 1919, when Parisian microbiologist Félix d’Hérelle gave a phage cocktail to a 12-year-old boy, apparently curing his severe dysentery. Yet despite early promise, research dried up in the 40s as the world began to adopt the quick medical fix of antibiotics.
Now, research is again gathering momentum as part of the solution to reduce antibiotic resistance. Although a promising alternative with some remarkable case studies of phage therapy working in individuals, one obstacle to wider use is that bacteria can rapidly evolve resistance to phages, via CRISPR-Cas immunity or via modification of their surface.
The researchers show that the effect of bacteriostatic antibiotics triggering CRISPR-Cas immunity results from slower phage replication inside the cell, which provides more time for the CRISPR-Cas system to acquire immunity and clear the phage infection. The research therefore identifies the speed of phage replication as a crucial factor controlling the possibility for CRISPR-Cas systems to defend against viruses.
Lead author Dr Tatiana Dimitiru, of the University of Exeter, said: This study provides fundamental insight into the constraints of CRISPR immune systems in the face of viruses. It was recently discovered that many CRISPR-Cas immune systems are associated to cell responses that make bacteria slow or stop growth upon phage infection, and we speculate that this may be important for cells to trigger an effective immune response.
Original Article: New research moves closer to harnessing viruses to fight bacteria and reduce antibiotic use
More from: University of Exeter
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Combining antibiotics and phage therapy
- Phage Cocktails and the Future of Phage Therapy
Nonetheless, there are several challenges that must be addressed prior to widespread adoption of phage ... of phage therapy (Figure 2), as it is thought to best fit a combination of constraints ...
- 'Phage therapy' could treat some drug-resistant superbug infections, but comes with unique challenges
staggered administration of single phages or combining phage therapy with other treatments. Antibiotics aren't "one size fits all" for bacterial infections, but one antibiotic covers many ...
- ‘Phage therapy’ could treat some drug-resistant superbug infections, but comes with unique challenges
staggered administration of single phages or combining phage therapy with other treatments. Antibiotics aren’t “one size fits all” for bacterial infections, but one antibiotic covers many ...
- Microbiome: the leading companies in bacteriophage therapy revealed
Bacteriophage therapy, also known as phage therapy, is a type of treatment that uses naturally ... making them a potential alternative to antibiotics and a promising option for treating bacterial ...
- Upgrading Phage Therapies to Crush Antimicrobial Resistance
such as antibiotics or wound-healing agents, to create combination therapies. “We are improving our hydrogel technology to [enhance] formulation so that it is compatible with phage therapy ...
Go deeper with Google Headlines on:
Combining antibiotics and phage therapy
[google_news title=”” keyword=”combining antibiotics and phage therapy” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Phage therapy
- Phage Cocktails and the Future of Phage Therapy
Nonetheless, there are several challenges that must be addressed prior to widespread adoption of phage therapy. In this section, the authors consider various strategies of phage formulation ...
- No antibiotics worked, so this woman turned to a natural enemy of bacteria to save her husband’s life
With her husband near death from an antibiotic-resistant superbug, a scientist found a cure no one had used in the US — intravenous injections of viruses called phages — and convinced the medical ...
- Phage Cocktails and the Future of Phage Therapy
Their potential as antibacterial agents was appreciated almost immediately, with the first 'phage therapy' trials predating Fleming's discovery of penicillin by approximately a decade. In this ...
- CNN's 'Vital Signs' explores the prospects of phage therapy to treat drug-resistant superbugs
Antibiotics have been hailed as a "miracle drug" since the discovery of penicillin in 1928, but now, more bacteria are developing resistance to antibiotics. In 2019, the United Nations estimated ...
- BiomX: BX004 Phage Cocktail Part 2, Phase 1b/2a Clinical Results In Cystic Fibrosis Expected Any Day
Published compassionate use of Phage treatment at Yale in CF is also ... addressing a significant unmet medical need as providing a therapy where none exists or providing a therapy which may ...
Go deeper with Google Headlines on:
Phage therapy
[google_news title=”” keyword=”phage therapy” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]